Lokesh Kadabur Nagendrapp, Sathyanarayanan Vishwanath, Kuntegowdanahalli C Lakshmaiah, Suresh T M, Dasappa Lokanatha, Kanakasetty Govinda Babu K
Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
Urol Ann. 2014 Jul;6(3):231-4. doi: 10.4103/0974-7796.134277.
Primary testicular lymphoma constitutes 1-2% of Non-Hodgkin's lymphomas affecting elderly men >60 years of age. Most often it is a Diffuse large B cell lymphoma (DLBCL) and treatment involves multimodality approach involving surgery, chemotherapy and radiotherapy. Outcome remains poor in spite of aggressive therapy.
We retrospectively reviewed 286 registered cases of DLBCL (aged >14 years) from 2007 to 2011 and found nine primary testicular involvement patients. These cases were analyzed for baseline clinical features, investigations, staging, treatment and outcome.
Median age was 58 (46-76) years. All patients presented with testicular swelling, two had the presence of B symptoms, and three with abdominal lymphadenopathy. Six had stage IE disease and three patients had stage IIE. All patients underwent orchiectomy. Eight patients received combination chemotherapy and six completed three or more cycles. Four achieved complete response, among these three relapsed after 32, 42, 70 months and one was lost to follow up. Two had a progressive disease, among these one died of disease and one alive with disease. Complete follow up was available from five patients and median survival was 36 months (11-78 months).
Primary testicular DLBCL is uncommon, needs multimodality treatment and central nervous system prophylaxis to improve the survival. The outcome needs to be further investigated using biological approaches (Rituximab based) and/or more aggressive management.
原发性睾丸淋巴瘤占影响60岁以上老年男性的非霍奇金淋巴瘤的1%-2%。最常见的是弥漫性大B细胞淋巴瘤(DLBCL),治疗采用包括手术、化疗和放疗的多模式方法。尽管进行了积极治疗,预后仍然很差。
我们回顾性分析了2007年至2011年登记的286例DLBCL(年龄>14岁)病例,发现9例原发性睾丸受累患者。对这些病例的基线临床特征、检查、分期、治疗和预后进行了分析。
中位年龄为58(46-76)岁。所有患者均表现为睾丸肿大,2例有B症状,3例有腹部淋巴结肿大。6例为IE期疾病,3例为IIE期。所有患者均接受了睾丸切除术。8例患者接受了联合化疗,6例完成了三个或更多周期。4例达到完全缓解,其中3例在32、42、70个月后复发,1例失访。2例病情进展,其中1例死于疾病,1例带瘤生存。5例患者有完整的随访记录,中位生存期为36个月(11-78个月)。
原发性睾丸DLBCL不常见,需要多模式治疗和中枢神经系统预防以提高生存率。需要使用生物方法(基于利妥昔单抗)和/或更积极的治疗方法进一步研究其预后。